Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | |
| Cash Flows From Operating Activities | |
| Net Income | -1,083 |
| Depreciation Amortization | 1 |
| Other Working Capital | 192 |
| Other Operating Activity | 22 |
| Operating Cash Flow | $-869 |
| Cash Flows From Investing Activities | |
| Investing Cash Flow | $N/A |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 1,850 |
| Financing Cash Flow | $1,850 |
| Beginning Cash Position | 445 |
| End Cash Position | 1,426 |
| Net Cash Flow | $981 |
| Free Cash Flow | |
| Operating Cash Flow | -869 |
| Free Cash Flow | -869 |